High throughput screening for neurodegeneration and complex disease phenotypes.

Area of Science:

• Neuroscience
• Genetics
• Pharmacology

Background:

• High throughput screening (HTS) faces challenges in complex disease phenotyping.
• Adapting complex phenotypes for rapid, high throughput assays is difficult.

Purpose of the Study:

• To describe the development of high throughput and high-content screens (HCS) for neurodegenerative diseases.
• To focus on inherited neurodegenerative disorders like Huntington's disease.

Main Methods:

• HTS assays targeting protein aggregation, neuronal death, caspase activation, and mutant protein clearance.
• High-content screens (HCS) for prioritizing hits from HTS.

Main Results:

• Development of novel HTS and HCS assays for neurodegenerative disease research.
• Demonstration of HCS utility in hit prioritization for complex phenotypes.

Conclusions:

• These screening approaches accelerate drug discovery for neurodegenerative disorders.
• The developed methods can guide screening for other complex disease phenotypes.